Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
40.99
+0.04 (0.10%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $5.25 billion as of April 28, 2026. Its market cap has increased by 122.48% in one year.
Market Cap
5.25B
Enterprise Value
5.25B
1-Year Change
122.48%
Ranking
Category
Stock Price
$40.99
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $5.25B, an increase of 659.23%. That is a compound annual growth rate of 27.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.23B | 64.70% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 5.80B |
| Rhythm Pharmaceuticals | 5.75B |
| Mirum Pharmaceuticals | 5.74B |
| Scholar Rock Holding | 5.57B |
| CG Oncology | 5.53B |
| Immunovant | 5.49B |
| Xenon Pharmaceuticals | 5.27B |
| Caris Life Sciences | 5.21B |